1
Used. With the current knowledge on the mixed effect on diseases, it might be feasible to find a representative cohort of new menopausal women without HT for follow-up studies.8.9.10. 11.Conclusion There was a notable variability in the development of disturbing vasomotor symptoms over time in a selected group of women aged 50 -59. Population-based followup studies of untreated women would be usef
1
Not included in the present analysis. The women in the blind arms received their drug bottles with coded labels (otherwise identical bottles). Women in the non-blind HT arm had their drug bottles marked with HT. Only data on women in blind placebo group and nontreatment group aged 50?9 at recruitment (n = 486) are used in this study. Throughout the trial, about 90 ofwomen in the non-treatment gro
1
Among all menopausal women (occurring in 16?2 of premenopausal, 39?7 of perimenopausal and 35?0* Correspondence: elina.hemminki@thl.fi 1 National Institute for Health and Welfare (THL), P.O. Box 3000271, Helsinki, Finland Full list of author information is available at the end of the articleof postmenopausal women). In a Finnish populationbased study by Hemminki et al. (1995), 28 of women aged
1
Men's experience of the menopause. Br J Obstet Gynaecol 1996, 103:1025?028. Mitchell ES, Woods NF: Symptom experiences of midlife women: observations from the Seattle midlife women's health study. Maturitas 1996, 25:1?0. Jokinen K, Rautava P, M inen J, Ojanlatva A, Sundell J, Helenius H: Experience of climacteric symptoms among 42?6 and 52?6-year-old women. Maturitas 2003, 46:199?05. Col NF, Guthr
1
Unmilola OM, Taiwo LO: Experience of menopausal symptoms by women in an urban community in Ibadan, Nigeria. Menopause 2008, 16:1?. 5. R str K, Bengtsson C, Lissner L, Milsom I, Sundh V, Bj kelund C: A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarter of a century. Menopause 2002, 9:156?61. 6. National Institutes of Health state of sci
1
Ncer diagnosis. Although in low proportion, longer medical delay have also been observed in previous studies, even in developed countries [13,23]. The observation of medical delay in Morrocco where 61 of patients had suffered 30 days' delay was similar to that of Nepal. The high proportion of health care provider delay in Nepal can be argued from various perspectives such as access to services, e
1
E not available for all women. Furthermore the numbers of women in early menopause were few. These complications of data led us to the crude analysis used in the study. However, our analysis was good enough to show the variability between women, and suggest the need for larger follow-up studies to describe the natural course of menopausal symptoms. To estimate the duration of symptoms among unsele
1
E not available for all women. Furthermore the numbers of women in early menopause were few. These complications of data led us to the crude analysis used in the study. However, our analysis was good enough to show the variability between women, and suggest the need for larger follow-up studies to describe the natural course of menopausal symptoms. To estimate the duration of symptoms among unsele